Bone growth after periosteal stripping in rats
✍ Scribed by G. L. Garcés; J. A. Hernández Hermoso
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 273 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0341-2695
No coin nor oath required. For personal study only.
✦ Synopsis
The effect on bone growth after stripping of the periosteum of the middle third of the femur was investigated in 70 rats. Seventy further animals were used as controls. The animals were serially killed at 1, 2, 4, 8, 12, 16 and 20 weeks after operation. The femoral length, intertrochanteric diameter, diameter of the distal epiphysis of the femur, diameter of the femoral diaphysis and the tibial length were measured. Significant lengthening of the femur was noted only after 4 weeks, when it was 1.5% longer than the opposite side (p 0.001), but this was not maintained. The diameter of the distal epiphysis and the tibial length were not significantly affected. The intertrochanteric diameter was significantly shorter on the stripped side at the 2nd week and significantly longer at the 12th. The diaphyseal diameter of the stripped bones was progressively more narrow than the contralateral from the 2nd week. Differences remained significant at all stages of this study. Periosteal stripping yields only a temporary slight increase in bone length with a definite decrease in diaphyseal diameter.
📜 SIMILAR VOLUMES
During growth the muscles of mastication alter their lines of action. Research on long bones indicates that the apparent migration of muscle attachments is due to the movement of the periosteum relative to the underlying bone. To assess whether the pig masseter muscle follows the periosteum during g
Male and female rats were fed a commercial diet lacking pyridoxine. Using radiological and histological methods the growth of the long bones in the pyridoxine-deficient rats from 2 wk to 6 mth of age was compared with that in paired-fed and in paired-weight-gain control rats of the same age and sex
Insulin-like growth factor (IGF)-I and IGF-II are expressed at biologically effective levels by bone cells. Their stability and activity are modulated by coexpression of IGF binding proteins (IGFBPs). Secreted IGFBPs may partition to soluble, cell-associated, and matrix-bound compartments. Extracell